Transcripts CSL Limited

Equities

Market Closed - Australian S.E. Other stock markets 02:10:42 2024-05-02 am EDT			5-day change	1st Jan Change
275.4 ^AUD	+0.33%		-1.28%	-3.93%

May. 01	Australian shares fall as miners and banks drag; Fed in focus	RE
Apr. 30	Ars Pharmaceuticals, Inc. Enters Exclusive License and Distribution Agreement with CSL Seqirus for Commercialization of Neffy in Australia and New Zealand	CI

Transcript : CSL Limited, H1 2024 Earnings Call, Feb 13, 2024	Feb. 12
Transcript : CSL Limited - Analyst/Investor Day	23-10-15
Transcript : CSL Limited - Shareholder/Analyst Call	23-10-10
Transcript : CSL Limited, 2023 Earnings Call, Aug 15, 2023	23-08-14
Transcript : CSL Limited - Special Call	23-06-13
Transcript : CSL Limited - Special Call	23-05-28
Transcript : CSL Limited, H1 2023 Earnings Call, Feb 14, 2023	23-02-13
Transcript : CSL Limited - Special Call	22-11-02
Transcript : CSL Limited - Special Call	22-10-16
Transcript : CSL Limited - Shareholder/Analyst Call	22-10-11
Transcript : CSL Limited, 2022 Earnings Call, Aug 17, 2022	22-08-16
CSL Limited Provides Earnings Guidance for the Fiscal Year 2023	22-08-16	CI
Transcript : CSL Limited, H1 2022 Earnings Call, Feb 16, 2022	22-02-15
CSL Limited Provides Earnings Guidance for the Fiscal Year 2022	22-02-15	CI
Transcript : CSL Limited, Vifor Pharma AG - M&A Call	21-12-14
Transcript : CSL Limited - Special Call	21-10-18
Transcript : CSL Limited - Shareholder/Analyst Call	21-10-11
CSL Limited Provides Earnings Guidance for Fiscal Year 2022	21-10-11	CI
Transcript : CSL Limited, 2021 Earnings Call, Aug 18, 2021	21-08-17
CSL Limited Provides Financial Guidance for Fiscal 2022	21-08-17	CI

No results for this search